Class 2 Medicines Recall: Accord Healthcare Ltd, Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion (1 vial 100mg powder, 1 vial of 3 mL solvent), EL(26)A/05

Guidance on the various types of modifications that can be made to a clinical trial approval.

Information for patients, public and healthcare professionals.

The appointment will involve a time commitment of approximately 22 days per year including 11 meetings. Remuneration for the roles will be at a rate of £325 per meeting.

An initiative to help drive advancements in healthcare, to ensure patients benefit from innovation and new treatments sooner.

List of Field Safety Notices from 10 to 14 November 2025.

Guidance on the updates to reporting forms following implementation of the Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024.